Association between nonalcoholic fatty liver disease and coronary artery disease complexity in patients with acute coronary syndrome: A pilot study

Angiology

Volumn 64, Issue 8, 2013, Pages 604-608

  Aǧaç, Mustafa Tarik ^a   Korkmaz, Levent ^a   Çavuşoǧlu, Gökhan ^a   Karadeniz, Ayşe Gül ^a   Aǧaç, Süret ^b   Bektas, Hüseyin ^a   Erkan, Hakan ^a   Varol, Mustafa Oguz ^a   Vatan, Mehmet Bulent ^c   Acar, Zeydin ^a   Menteşe, Ümit ^a   Çelik, Şükrü ^a  

^a Ahi Evren Heart and Vascular Surgery Training and Research Hospital   (Turkey)

^b KARADENIZ TECHNICAL UNIVERSITY   (Turkey)

^c SAKARYA UNIVERSITY   (Turkey)

Author keywords

acute coronary syndrome; nonalcoholic fatty liver disease; SYNTAX score

Indexed keywords

ACUTE CORONARY SYNDROME; ADULT; ARTICLE; CONTROLLED STUDY; CORONARY ARTERY DISEASE; DISEASE ASSOCIATION; FATTY LIVER; FEMALE; HUMAN; MAJOR CLINICAL STUDY; MALE; NONALCOHOLIC FATTY LIVER; PILOT STUDY; PREVALENCE; SYNTAX SCORE;

ACUTE CORONARY SYNDROME; NONALCOHOLIC FATTY LIVER DISEASE; SYNTAX SCORE;

ACUTE CORONARY SYNDROME; AGED; COMORBIDITY; CORONARY ANGIOGRAPHY; FATTY LIVER; FEMALE; HUMANS; MALE; MIDDLE AGED; MULTIVARIATE ANALYSIS; PERCUTANEOUS CORONARY INTERVENTION; PILOT PROJECTS; PREVALENCE; RISK FACTORS; SEVERITY OF ILLNESS INDEX;

EID: 84885078130     PISSN: 00033197     EISSN: 19401574     Source Type: Journal    
DOI: 10.1177/0003319713479155     Document Type: Article

References (18)

1. Targher G, Arcaro G. Non-alcoholic fatty liver disease and increased risk of cardiovascular disease. Atherosclerosis. 2007 ; 191 (2). 235-240
2. Targher G, Bertolini L, Padovani R, et al. Increased prevalence of cardiovascular disease among type 2 diabetic patients with non-alcoholic fatty liver disease. Diabet Met. 2006 ; 23 (4). 403-409
3. Lin YC, Lo HM, Chen JD. Sonographic fatty liver, overweight and ischemic heart disease. World J Gastroenterol. 2005 ; 11 (31). 4838-4842
4. Kessler A, Levy Y, Roth A, et al. Increased prevalence of NAFLD in patients with acute myocardial infarction independent of BMI. Hepatology. 2005 ; 42 (4 suppl 1). 623A
5. Arslan U, Turkoglu S, Balcioglu S, Tavil Y, Karakan T, Cengel A. Association between nonalcoholic fatty liver disease and coronary artery disease. Coron Artery Dis. 2007 ; 18 (6). 433-436
6. Alper AT, Hasdemir H, Sahin S, et al. The relationship between nonalcoholic fatty liver disease and the severity of coronary artery disease in patients with metabolic syndrome. Turk Kardiyol Dern Ars. 2008 ; 36 (6). 376-381
7. Palmerini T, Genereux P, Caixeta A, et al. Prognostic value of the SYNTAX score in patients with acute coronary syndromes undergoing percutaneous coronary intervention: analysis from the ACUITY (Acute Catheterization and Urgent Intervention Triage StrategY) trial. J Am Coll Cardiol. 2011 ; 57 (24). 2389-2397
8. Sianos G, Morel MA, Kappetein AP, et al. The SYNTAX Score: an angiographic tool grading the complexity of coronary artery disease. EuroIntervention. 2005 ; 1 (2). 219-227
9. Alberti KG, Zimmet P, Shaw J. The metabolic syndrome - a new worldwide definition. Lancet. 2005 ; 366 (9491). 1059-1062
10. SYNTAX Working Group. SYNTAX score calculator. http://www.syntaxscore. com. Accessed 22 September 2012.
11. Saverymuttu SH, Joseph AE, Maxwell JD. Ultrasound scanning in the detection of hepatic fibrosis and steatosis. Br Med J. 1986 ; 292 (6412). 13-15
12. AcIkel M, Sunay S, Kolpay M, Gundogdu F, Karakelleoglu S. Evaluation of ultrasonographic fatty liver and severity of coronary atherosclerosis, and obesity in patients undergoing coronary angiography. Anadolu Kardiyol Derg. 2009 ; 9 (4). 273-279
13. Ling S, Shu-Zheng L. Association between non-alcoholic fatty liver disease and coronary artery disease severity. Chin Med J. 2011 ; 124 (6). 867-872
14. Gensini GG. A meaningful scoring system for determining the severity of coronary heart disease. Am J Cardiol. 1983 ; 51 (3). 606
15. Athyros VG, Tziomalos K, Gossios TD, et al. Safety and efficacy of long-term statin treatment for cardiovascular events in patients with coronary heart disease and abnormal liver tests in the Greek Atorvastatin and Coronary Heart Disease Evaluation (GREACE) Study: a post-hoc analysis. Lancet. 2010 ; 376 (9756). 1916-1922
16. Zein CO, Unalp A, Colvin R, Liu YC, McCullough AJ. Smoking and severity of hepatic fibrosis in nonalcoholic fatty liver disease. J Hepatol. 2011 ; 54 (4). 753-759
17. Korkmaz L, Adar A, Korkmaz AA, et al. Atherosclerosis burden and coronary artery lesion complexity in acute coronary syndrome patients. Cardiol. J. 2012 ; 19 (3). 295-300
18. Joseph AE, Saverymuttu SH, al-Sam S, Cook MG, Maxwell JD. Comparison of liver histology with ultrasonography in assessing diffuse parenchymal liver disease. Clin Radiol. 1991 ; 43 (1). 26-31